Trial Profile
Comparative Pharmacokinetics of AFOLIA and US Gonal-f RFF Redi-ject After Single Subcutaneous Application. A Randomised, Open Label, 2-way Cross-over Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Pharmacokinetics
- Sponsors Fertility Biotech
- 17 Feb 2017 Status changed from recruiting to completed.
- 04 Jun 2015 New trial record